These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10714959)

  • 1. Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited.
    Hill BT; Perrin D; Kruczynski A
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):7-23. PubMed ID: 10714959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
    Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
    Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of protein farnesyltransferase as novel anticancer agents.
    Ohkanda J; Knowles DB; Blaskovich MA; Sebti SM; Hamilton AD
    Curr Top Med Chem; 2002 Mar; 2(3):303-23. PubMed ID: 11944822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ras prenylation: a novel approach to cancer chemotherapy.
    Sebti SM; Hamilton AD
    Pharmacol Ther; 1997; 74(1):103-14. PubMed ID: 9336018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.
    Lobell RB; Liu D; Buser CA; Davide JP; DePuy E; Hamilton K; Koblan KS; Lee Y; Mosser S; Motzel SL; Abbruzzese JL; Fuchs CS; Rowinsky EK; Rubin EH; Sharma S; Deutsch PJ; Mazina KE; Morrison BW; Wildonger L; Yao SL; Kohl NE
    Mol Cancer Ther; 2002 Jul; 1(9):747-58. PubMed ID: 12479371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.
    Whyte DB; Kirschmeier P; Hockenberry TN; Nunez-Oliva I; James L; Catino JJ; Bishop WR; Pai JK
    J Biol Chem; 1997 May; 272(22):14459-64. PubMed ID: 9162087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
    Sebti SM; Hamilton AD
    Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development.
    Rowinsky EK; Windle JJ; Von Hoff DD
    J Clin Oncol; 1999 Nov; 17(11):3631-52. PubMed ID: 10550163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyl transferase inhibitors--a novel therapy for breast cancer.
    Johnston SR; Kelland LR
    Endocr Relat Cancer; 2001 Sep; 8(3):227-35. PubMed ID: 11566614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein prenylation: unique fats make their mark on biology.
    Wang M; Casey PJ
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):110-22. PubMed ID: 26790532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ras function in vitro and in vivo using inhibitors of farnesyl-protein transferase.
    Kohl NE; Wilson FR; Thomas TJ; Bock RL; Mosser SD; Oliff A; Gibbs JB
    Methods Enzymol; 1995; 255():378-86. PubMed ID: 8524123
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.
    End DW; Smets G; Todd AV; Applegate TL; Fuery CJ; Angibaud P; Venet M; Sanz G; Poignet H; Skrzat S; Devine A; Wouters W; Bowden C
    Cancer Res; 2001 Jan; 61(1):131-7. PubMed ID: 11196150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer.
    Johnston SR
    Lancet Oncol; 2001 Jan; 2(1):18-26. PubMed ID: 11905614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
    Cox AD; Der CJ
    Biochim Biophys Acta; 1997 Aug; 1333(1):F51-71. PubMed ID: 9294018
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
    Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using inhibitors of prenylation to block localization and transforming activity.
    Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
    Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.